O-Me Eribulin
O-Me Eribulin is a derivative of Eribulin and is an ADC cytotoxin that can be used for ADC synthesis. O-Me Eribulin can inhibit the cell viability of SKBR3, MDA-MB-468, and A549 cells, with IC50 values of 0.2052, 0.1827, and 0.5151 nM, respectively. O-Me Eribulin can be used for tumor research[1].
Product Specifications
CAS Number
2676196-81-7
Product Name Alternative
O-Me B1939; O-Me E7389; O-Me ER-086526
UNSPSC
12352203
Target
ADC Payload
Type
Reference compound
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/o-me-eribulin.html
Smiles
Molecular Formula
C41H61NO11
Molecular Weight
743.92
References & Citations
[1]Sun xing, et al. Drug conjugate of eribulin derivative. CN2022/107479. 2023-01-26.
Shipping Conditions
Room temperature
Scientific Category
ADC Related
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog